Announced
Completed
Bain Capital, and Cinven, to make an offer for the 63% of STADA Arzneimittel AG's shares.
Synopsis
Bain Capital, private equity firm, and Cinven, private equity firm, acquired 63% of the outstanding shares of the German generic drugmaker STADA Arzneimittel.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.